MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s 19th annual scorecard on... Read more
WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s 19th annual scorecard on... Read more
Thermo Fisher Scientific Named “Best Place to Work for LGBTQ Equality” for Sixth Consecutive Year WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on... Read more
Germantown, Maryland, and Hilden, Germany, January 28, 2021 – QIAGEN today announced the addition of kits for wastewater testing to its growing portfolio of COVID-19 products. The use of dPCR in the worldwide surveillance of COVID-19 is an additional step towards making digital PCR (dPCR) an affordable and standard instrument for a host of applications... Read more
MINNEAPOLIS, Jan. 28, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced an initial minority strategic equity investment in Changzhou Eminence Biotechnology Co., Ltd. (“Eminence”). Eminence will use the financing proceeds to expand its manufacturing capacity and increase the... Read more
January 28, 2021 BioTek Instruments, an Agilent Technologies, Inc., company, announces that it was granted a patent by the United States Patent and Trademark Office for the Automated Media Exchange (AMX) module for the MultiFlo FX Multi-Mode Dispenser. In cell biology workflows, the automated MultiFlo FX with AMX module enables hands-free, gentle, and highly consistent media exchanges and washing... Read more
The new Antibody Discovery Module accelerates and improves candidate selection workflows Caption: ENPICOM’s solution accelerates and improves antibody discovery. To download image, please click here. ‘s-Hertogenbosch (The Netherlands) – January 28, 2020 – Life Science Newswire – ENPICOM BV, an innovative bioinformatics software engineering company, announces a major release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module (ADM). This... Read more